| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Irritable Bowel Syndrome | 67 | 2025 | 205 | 18.830 |
Why?
|
| Abdominal Pain | 63 | 2025 | 306 | 11.220 |
Why?
|
| Gastroparesis | 29 | 2024 | 65 | 8.710 |
Why?
|
| Gastrointestinal Diseases | 34 | 2023 | 339 | 7.860 |
Why?
|
| Dyspepsia | 10 | 2024 | 102 | 4.180 |
Why?
|
| Feces | 29 | 2025 | 727 | 3.540 |
Why?
|
| Constipation | 14 | 2023 | 114 | 3.410 |
Why?
|
| Gastrointestinal Microbiome | 17 | 2025 | 698 | 3.380 |
Why?
|
| Gastric Emptying | 23 | 2024 | 78 | 2.560 |
Why?
|
| Intestinal Mucosa | 22 | 2024 | 780 | 2.480 |
Why?
|
| Gastroenterology | 11 | 2024 | 201 | 2.460 |
Why?
|
| Child | 122 | 2025 | 24608 | 2.390 |
Why?
|
| Infant, Premature | 23 | 2024 | 833 | 2.220 |
Why?
|
| Infant Nutritional Physiological Phenomena | 12 | 2024 | 193 | 2.140 |
Why?
|
| Probiotics | 8 | 2022 | 215 | 2.130 |
Why?
|
| Plant Oils | 4 | 2022 | 33 | 1.990 |
Why?
|
| Quality of Life | 26 | 2023 | 1909 | 1.970 |
Why?
|
| Surveys and Questionnaires | 28 | 2024 | 3689 | 1.850 |
Why?
|
| Humans | 250 | 2025 | 125309 | 1.770 |
Why?
|
| Diarrhea | 11 | 2025 | 317 | 1.740 |
Why?
|
| Colic | 3 | 2022 | 9 | 1.700 |
Why?
|
| Malabsorption Syndromes | 6 | 2018 | 36 | 1.670 |
Why?
|
| Dietary Carbohydrates | 11 | 2025 | 119 | 1.620 |
Why?
|
| Psyllium | 3 | 2023 | 11 | 1.600 |
Why?
|
| Intestine, Small | 17 | 2021 | 309 | 1.560 |
Why?
|
| Somatoform Disorders | 5 | 2021 | 46 | 1.500 |
Why?
|
| Enteral Nutrition | 13 | 2023 | 259 | 1.480 |
Why?
|
| Adolescent | 65 | 2025 | 19424 | 1.450 |
Why?
|
| Severity of Illness Index | 21 | 2021 | 2908 | 1.430 |
Why?
|
| Nausea | 13 | 2024 | 84 | 1.410 |
Why?
|
| Gastroesophageal Reflux | 5 | 2023 | 327 | 1.400 |
Why?
|
| Vomiting | 10 | 2024 | 103 | 1.390 |
Why?
|
| Dietary Fiber | 6 | 2023 | 75 | 1.370 |
Why?
|
| Female | 133 | 2025 | 66791 | 1.330 |
Why?
|
| Male | 120 | 2025 | 61531 | 1.260 |
Why?
|
| Menthol | 2 | 2021 | 5 | 1.250 |
Why?
|
| Gastrointestinal Tract | 8 | 2023 | 213 | 1.200 |
Why?
|
| Lactulose | 13 | 2019 | 39 | 1.190 |
Why?
|
| Parenteral Nutrition | 14 | 2023 | 196 | 1.170 |
Why?
|
| Symptom Assessment | 4 | 2021 | 101 | 1.140 |
Why?
|
| Milk, Human | 6 | 2024 | 300 | 1.120 |
Why?
|
| Stomach | 5 | 2024 | 270 | 1.100 |
Why?
|
| Infant Formula | 3 | 2024 | 97 | 1.100 |
Why?
|
| Intestinal Absorption | 16 | 2014 | 190 | 1.090 |
Why?
|
| Anxiety | 13 | 2023 | 944 | 1.060 |
Why?
|
| Microbiota | 7 | 2023 | 387 | 1.040 |
Why?
|
| Fermentation | 8 | 2025 | 66 | 1.010 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2017 | 303 | 0.990 |
Why?
|
| Pediatrics | 11 | 2020 | 1158 | 0.990 |
Why?
|
| Parenteral Nutrition, Total | 18 | 2005 | 113 | 0.970 |
Why?
|
| Eating | 3 | 2022 | 369 | 0.930 |
Why?
|
| Fructans | 3 | 2021 | 10 | 0.930 |
Why?
|
| Diet | 11 | 2023 | 1138 | 0.930 |
Why?
|
| Defecation | 6 | 2023 | 30 | 0.930 |
Why?
|
| Milk | 4 | 2024 | 119 | 0.910 |
Why?
|
| Child, Preschool | 52 | 2025 | 14145 | 0.880 |
Why?
|
| Permeability | 9 | 2019 | 124 | 0.860 |
Why?
|
| Colonic Diseases, Functional | 4 | 2023 | 14 | 0.860 |
Why?
|
| Infant Food | 8 | 2018 | 81 | 0.840 |
Why?
|
| Nutritional Sciences | 2 | 2015 | 75 | 0.830 |
Why?
|
| RNA, Ribosomal, 16S | 12 | 2024 | 363 | 0.820 |
Why?
|
| Esophagus | 2 | 2015 | 223 | 0.820 |
Why?
|
| Double-Blind Method | 15 | 2023 | 1634 | 0.810 |
Why?
|
| Infant, Newborn | 47 | 2024 | 8273 | 0.810 |
Why?
|
| Gastrointestinal Motility | 3 | 2021 | 48 | 0.800 |
Why?
|
| Glucose | 20 | 2003 | 878 | 0.790 |
Why?
|
| Intestinal Diseases | 7 | 2016 | 83 | 0.780 |
Why?
|
| Digestion | 4 | 2018 | 41 | 0.780 |
Why?
|
| Monosaccharides | 7 | 2025 | 23 | 0.770 |
Why?
|
| Cytokines | 4 | 2025 | 1289 | 0.750 |
Why?
|
| Mannitol | 8 | 2016 | 48 | 0.750 |
Why?
|
| Prospective Studies | 21 | 2024 | 6140 | 0.750 |
Why?
|
| Insulins | 1 | 2021 | 17 | 0.740 |
Why?
|
| Oligosaccharides | 8 | 2025 | 75 | 0.740 |
Why?
|
| Gastrointestinal Agents | 7 | 2014 | 62 | 0.740 |
Why?
|
| Reflex | 1 | 2021 | 51 | 0.740 |
Why?
|
| Meals | 2 | 2022 | 57 | 0.730 |
Why?
|
| Neuroimmunomodulation | 2 | 2018 | 15 | 0.720 |
Why?
|
| beta-Defensins | 1 | 2020 | 12 | 0.700 |
Why?
|
| Child Nutritional Physiological Phenomena | 5 | 2016 | 174 | 0.700 |
Why?
|
| Brain | 10 | 2025 | 3011 | 0.690 |
Why?
|
| Starch | 2 | 2018 | 25 | 0.690 |
Why?
|
| Diet, Carbohydrate-Restricted | 4 | 2023 | 25 | 0.690 |
Why?
|
| alpha-Glucosidases | 5 | 2018 | 28 | 0.680 |
Why?
|
| Joint Instability | 1 | 2020 | 43 | 0.660 |
Why?
|
| Mentha piperita | 4 | 2022 | 9 | 0.650 |
Why?
|
| Dietary Supplements | 4 | 2019 | 472 | 0.650 |
Why?
|
| Sus scrofa | 1 | 2020 | 122 | 0.650 |
Why?
|
| Chronic Pain | 1 | 2021 | 121 | 0.630 |
Why?
|
| Radionuclide Imaging | 9 | 2023 | 150 | 0.630 |
Why?
|
| Lactose | 6 | 2009 | 54 | 0.630 |
Why?
|
| Catastrophization | 1 | 2018 | 15 | 0.620 |
Why?
|
| Infant | 42 | 2024 | 12602 | 0.620 |
Why?
|
| Leukocyte L1 Antigen Complex | 4 | 2022 | 15 | 0.610 |
Why?
|
| Chromogranins | 1 | 2018 | 26 | 0.610 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 48 | 0.600 |
Why?
|
| Prevalence | 8 | 2024 | 2466 | 0.590 |
Why?
|
| Hydrogen | 6 | 2017 | 41 | 0.580 |
Why?
|
| Catheterization, Central Venous | 7 | 2011 | 130 | 0.580 |
Why?
|
| Bacteria | 5 | 2024 | 481 | 0.580 |
Why?
|
| Pain Threshold | 3 | 2016 | 20 | 0.580 |
Why?
|
| Models, Animal | 1 | 2020 | 456 | 0.580 |
Why?
|
| Sex Characteristics | 1 | 2019 | 314 | 0.570 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2015 | 76 | 0.560 |
Why?
|
| Photography | 2 | 2024 | 95 | 0.560 |
Why?
|
| Pain | 3 | 2017 | 447 | 0.550 |
Why?
|
| Disaccharides | 5 | 2025 | 14 | 0.550 |
Why?
|
| Cholestasis | 6 | 2007 | 155 | 0.540 |
Why?
|
| Health Communication | 1 | 2017 | 27 | 0.540 |
Why?
|
| Cisapride | 4 | 2000 | 5 | 0.530 |
Why?
|
| Food Intolerance | 1 | 2016 | 2 | 0.530 |
Why?
|
| Lactase | 10 | 2010 | 40 | 0.520 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 21 | 0.520 |
Why?
|
| Food Hypersensitivity | 3 | 2016 | 154 | 0.510 |
Why?
|
| Bottle Feeding | 6 | 2007 | 36 | 0.500 |
Why?
|
| Deglutition | 2 | 2015 | 51 | 0.490 |
Why?
|
| Endoscopy, Digestive System | 3 | 2013 | 152 | 0.490 |
Why?
|
| Antiemetics | 1 | 2015 | 22 | 0.480 |
Why?
|
| Magnetic Resonance Spectroscopy | 14 | 2001 | 295 | 0.480 |
Why?
|
| Parents | 11 | 2021 | 1023 | 0.480 |
Why?
|
| Health Records, Personal | 1 | 2015 | 18 | 0.480 |
Why?
|
| Animals, Newborn | 13 | 2020 | 1018 | 0.480 |
Why?
|
| Self Concept | 1 | 2016 | 152 | 0.480 |
Why?
|
| Glutamine | 10 | 2001 | 215 | 0.470 |
Why?
|
| Pain Measurement | 6 | 2016 | 344 | 0.470 |
Why?
|
| Growth | 3 | 2012 | 106 | 0.470 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 136 | 0.460 |
Why?
|
| Short Bowel Syndrome | 3 | 2020 | 66 | 0.460 |
Why?
|
| Child Development | 6 | 2019 | 268 | 0.460 |
Why?
|
| Intestines | 6 | 2015 | 577 | 0.460 |
Why?
|
| Cross-Sectional Studies | 8 | 2024 | 3403 | 0.450 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2012 | 43 | 0.450 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2014 | 241 | 0.450 |
Why?
|
| Breath Tests | 8 | 2017 | 178 | 0.440 |
Why?
|
| Decontamination | 2 | 2024 | 11 | 0.440 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 208 | 0.440 |
Why?
|
| Esophagitis, Peptic | 1 | 2014 | 37 | 0.440 |
Why?
|
| Crohn Disease | 2 | 2016 | 279 | 0.430 |
Why?
|
| Nutritional Status | 3 | 2015 | 316 | 0.430 |
Why?
|
| Insulin | 13 | 2002 | 1203 | 0.430 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 403 | 0.430 |
Why?
|
| Celiac Disease | 2 | 2013 | 67 | 0.420 |
Why?
|
| Nociceptive Pain | 1 | 2013 | 4 | 0.420 |
Why?
|
| Adult | 43 | 2025 | 29528 | 0.420 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 133 | 0.420 |
Why?
|
| Age Factors | 12 | 2016 | 2817 | 0.420 |
Why?
|
| Cattle | 3 | 2024 | 567 | 0.420 |
Why?
|
| Pilot Projects | 6 | 2023 | 1398 | 0.410 |
Why?
|
| Precision Medicine | 1 | 2016 | 321 | 0.410 |
Why?
|
| Disaccharidases | 7 | 1994 | 15 | 0.410 |
Why?
|
| beta-Galactosidase | 9 | 2002 | 147 | 0.410 |
Why?
|
| Gallbladder | 2 | 2012 | 20 | 0.410 |
Why?
|
| Treatment Outcome | 19 | 2023 | 12282 | 0.410 |
Why?
|
| Micronutrients | 4 | 2022 | 70 | 0.400 |
Why?
|
| Interleukin-10 | 1 | 2014 | 174 | 0.400 |
Why?
|
| Case-Control Studies | 13 | 2021 | 3307 | 0.400 |
Why?
|
| Glutamic Acid | 8 | 2001 | 203 | 0.400 |
Why?
|
| Biliary Dyskinesia | 1 | 2012 | 5 | 0.390 |
Why?
|
| Methane | 3 | 2017 | 13 | 0.390 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 630 | 0.390 |
Why?
|
| Depression | 6 | 2021 | 1230 | 0.390 |
Why?
|
| Gallbladder Diseases | 1 | 2012 | 24 | 0.390 |
Why?
|
| Zinc | 5 | 2016 | 135 | 0.390 |
Why?
|
| Mood Disorders | 2 | 2024 | 125 | 0.390 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 2879 | 0.390 |
Why?
|
| Aspirin | 1 | 2013 | 222 | 0.370 |
Why?
|
| Nutritive Value | 2 | 2024 | 92 | 0.370 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 732 | 0.370 |
Why?
|
| Sex Factors | 5 | 2025 | 1275 | 0.360 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 304 | 0.360 |
Why?
|
| Teaching | 1 | 2012 | 188 | 0.350 |
Why?
|
| Dietary Sucrose | 2 | 2012 | 42 | 0.350 |
Why?
|
| Gastrointestinal Contents | 1 | 2010 | 13 | 0.350 |
Why?
|
| Cross Infection | 2 | 2024 | 325 | 0.350 |
Why?
|
| Palatine Tonsil | 1 | 2010 | 36 | 0.350 |
Why?
|
| Gastritis | 1 | 2014 | 372 | 0.350 |
Why?
|
| Growth Disorders | 3 | 2019 | 209 | 0.340 |
Why?
|
| Referral and Consultation | 2 | 2017 | 543 | 0.340 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 74 | 0.330 |
Why?
|
| Animals | 38 | 2024 | 34309 | 0.320 |
Why?
|
| Inflammation | 4 | 2014 | 1445 | 0.320 |
Why?
|
| Gastrointestinal Transit | 3 | 2020 | 22 | 0.320 |
Why?
|
| Stress, Psychological | 6 | 2017 | 550 | 0.320 |
Why?
|
| Retrospective Studies | 13 | 2023 | 16360 | 0.320 |
Why?
|
| Metagenome | 5 | 2015 | 148 | 0.320 |
Why?
|
| Hydrocortisone | 4 | 2015 | 217 | 0.320 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 282 | 0.310 |
Why?
|
| Clostridium Infections | 2 | 2023 | 245 | 0.310 |
Why?
|
| Citric Acid Cycle | 2 | 2001 | 47 | 0.310 |
Why?
|
| Infant, Premature, Diseases | 5 | 2005 | 245 | 0.310 |
Why?
|
| Child Nutrition Disorders | 2 | 2016 | 75 | 0.310 |
Why?
|
| Ammonia | 5 | 2001 | 76 | 0.300 |
Why?
|
| Education, Medical | 1 | 2012 | 289 | 0.300 |
Why?
|
| Diarrhea, Infantile | 6 | 1991 | 35 | 0.300 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2008 | 15 | 0.300 |
Why?
|
| Fat Emulsions, Intravenous | 7 | 2003 | 77 | 0.290 |
Why?
|
| Young Adult | 14 | 2025 | 9055 | 0.290 |
Why?
|
| Primary Health Care | 2 | 2017 | 774 | 0.290 |
Why?
|
| Placebos | 3 | 2017 | 241 | 0.280 |
Why?
|
| Smoking | 1 | 2013 | 1048 | 0.280 |
Why?
|
| Diabetes Complications | 2 | 2019 | 203 | 0.280 |
Why?
|
| Glutamates | 5 | 1992 | 68 | 0.280 |
Why?
|
| Lactobacillus | 2 | 2015 | 46 | 0.280 |
Why?
|
| Sucking Behavior | 3 | 2007 | 21 | 0.280 |
Why?
|
| Steroids | 1 | 2008 | 202 | 0.270 |
Why?
|
| Curriculum | 1 | 2012 | 727 | 0.270 |
Why?
|
| Nitrogen | 6 | 1995 | 145 | 0.270 |
Why?
|
| Liver Diseases | 2 | 2020 | 368 | 0.270 |
Why?
|
| Vitamins | 5 | 2016 | 108 | 0.260 |
Why?
|
| Biomarkers | 8 | 2020 | 3102 | 0.260 |
Why?
|
| Gestational Age | 10 | 2010 | 1169 | 0.260 |
Why?
|
| Swine, Miniature | 13 | 1997 | 49 | 0.260 |
Why?
|
| Glycogen | 4 | 1996 | 63 | 0.260 |
Why?
|
| Sleep Wake Disorders | 2 | 2021 | 168 | 0.260 |
Why?
|
| Malawi | 9 | 2019 | 398 | 0.260 |
Why?
|
| United States | 8 | 2024 | 10907 | 0.250 |
Why?
|
| Recurrence | 6 | 2022 | 1394 | 0.250 |
Why?
|
| Vitamin D | 3 | 2024 | 165 | 0.250 |
Why?
|
| Biopsy | 4 | 2015 | 1244 | 0.250 |
Why?
|
| Health Care Costs | 1 | 2009 | 372 | 0.250 |
Why?
|
| Blood Specimen Collection | 2 | 1998 | 48 | 0.250 |
Why?
|
| Malnutrition | 3 | 2019 | 209 | 0.240 |
Why?
|
| Albendazole | 2 | 2016 | 29 | 0.240 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 316 | 0.240 |
Why?
|
| Dysbiosis | 2 | 2018 | 122 | 0.240 |
Why?
|
| Gastroenteritis | 1 | 2008 | 348 | 0.240 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 455 | 0.240 |
Why?
|
| Heart Rate | 3 | 2016 | 592 | 0.230 |
Why?
|
| Breast Feeding | 3 | 2006 | 221 | 0.230 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1320 | 0.230 |
Why?
|
| Proteome | 2 | 2019 | 246 | 0.230 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2024 | 45 | 0.230 |
Why?
|
| Analysis of Variance | 6 | 2013 | 1017 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2010 | 518 | 0.220 |
Why?
|
| Self Report | 3 | 2016 | 508 | 0.220 |
Why?
|
| Polymers | 3 | 2025 | 104 | 0.220 |
Why?
|
| Affect | 1 | 2024 | 156 | 0.220 |
Why?
|
| Swine | 18 | 1997 | 1178 | 0.210 |
Why?
|
| Middle Aged | 19 | 2025 | 26741 | 0.210 |
Why?
|
| Digestive System | 2 | 2002 | 63 | 0.210 |
Why?
|
| Serotonin | 1 | 2024 | 217 | 0.210 |
Why?
|
| Attitude to Health | 2 | 2015 | 257 | 0.210 |
Why?
|
| Oryza | 2 | 1995 | 24 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2016 | 2812 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2016 | 778 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2023 | 1118 | 0.210 |
Why?
|
| Weight Gain | 5 | 2021 | 400 | 0.200 |
Why?
|
| Hypersensitivity | 2 | 2015 | 185 | 0.200 |
Why?
|
| Hydrochloric Acid | 2 | 1995 | 14 | 0.200 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 10 | 0.200 |
Why?
|
| Ileum | 3 | 1992 | 134 | 0.200 |
Why?
|
| Phosphates | 4 | 1996 | 115 | 0.200 |
Why?
|
| Isoflavones | 1 | 2022 | 43 | 0.200 |
Why?
|
| Bacteroidetes | 1 | 2022 | 20 | 0.190 |
Why?
|
| United Nations | 1 | 2002 | 12 | 0.190 |
Why?
|
| Patient Compliance | 2 | 2023 | 471 | 0.190 |
Why?
|
| Food, Fortified | 2 | 2000 | 96 | 0.190 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 2181 | 0.190 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 5165 | 0.190 |
Why?
|
| Time Factors | 9 | 2015 | 6308 | 0.190 |
Why?
|
| Catecholamines | 1 | 2001 | 59 | 0.190 |
Why?
|
| Infant Nutrition Disorders | 2 | 2019 | 28 | 0.180 |
Why?
|
| Domperidone | 1 | 2021 | 6 | 0.180 |
Why?
|
| Politics | 1 | 2002 | 59 | 0.180 |
Why?
|
| Trefoil Factor-3 | 2 | 2018 | 4 | 0.170 |
Why?
|
| Glycoside Hydrolases | 2 | 2012 | 17 | 0.170 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 13 | 0.170 |
Why?
|
| Bacterial Infections | 2 | 2022 | 307 | 0.170 |
Why?
|
| Urine | 2 | 2018 | 91 | 0.170 |
Why?
|
| Bifidobacterium | 1 | 2020 | 62 | 0.170 |
Why?
|
| Colon | 2 | 2015 | 352 | 0.170 |
Why?
|
| Scleroderma, Systemic | 1 | 2021 | 117 | 0.170 |
Why?
|
| Tryptophan | 2 | 2023 | 91 | 0.170 |
Why?
|
| Tertiary Care Centers | 3 | 2021 | 237 | 0.170 |
Why?
|
| Lactates | 7 | 1996 | 94 | 0.170 |
Why?
|
| Vagus Nerve | 3 | 2024 | 44 | 0.170 |
Why?
|
| Coinfection | 1 | 2022 | 172 | 0.170 |
Why?
|
| Research | 1 | 2002 | 262 | 0.170 |
Why?
|
| Sucrose | 3 | 2010 | 39 | 0.170 |
Why?
|
| Immune System | 1 | 2020 | 90 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2001 | 384 | 0.160 |
Why?
|
| Energy Intake | 6 | 2014 | 493 | 0.160 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 1999 | 135 | 0.160 |
Why?
|
| Feeding Behavior | 4 | 2010 | 699 | 0.160 |
Why?
|
| Sprue, Tropical | 1 | 2019 | 3 | 0.160 |
Why?
|
| Self-Management | 1 | 2021 | 95 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 264 | 0.160 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 42 | 0.160 |
Why?
|
| Pain Perception | 1 | 2019 | 4 | 0.160 |
Why?
|
| Muramidase | 1 | 2019 | 94 | 0.160 |
Why?
|
| Statistics, Nonparametric | 2 | 2019 | 433 | 0.160 |
Why?
|
| Chronic Disease | 6 | 2013 | 1187 | 0.160 |
Why?
|
| Respiratory Sinus Arrhythmia | 1 | 2018 | 9 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 1694 | 0.160 |
Why?
|
| Gray Matter | 1 | 2019 | 32 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 292 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 102 | 0.150 |
Why?
|
| Sleep | 3 | 2021 | 346 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 2019 | 93 | 0.150 |
Why?
|
| Blood Glucose | 10 | 2001 | 1134 | 0.150 |
Why?
|
| Lactoferrin | 1 | 2019 | 78 | 0.150 |
Why?
|
| Rural Population | 4 | 2016 | 256 | 0.150 |
Why?
|
| Sugar Alcohols | 1 | 2018 | 3 | 0.150 |
Why?
|
| Aminoglycosides | 1 | 1998 | 45 | 0.150 |
Why?
|
| Food | 2 | 2013 | 125 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 261 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 6 | 2000 | 167 | 0.150 |
Why?
|
| Muscles | 4 | 1994 | 292 | 0.150 |
Why?
|
| Internet | 2 | 2018 | 375 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 392 | 0.140 |
Why?
|
| Physical Exertion | 2 | 1996 | 78 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 244 | 0.140 |
Why?
|
| Diet Therapy | 1 | 2018 | 41 | 0.140 |
Why?
|
| Esophageal Stenosis | 2 | 2006 | 46 | 0.140 |
Why?
|
| Veins | 1 | 1998 | 105 | 0.140 |
Why?
|
| Anxiety Disorders | 2 | 2021 | 689 | 0.140 |
Why?
|
| Administration, Oral | 3 | 2015 | 682 | 0.140 |
Why?
|
| Prognosis | 3 | 2017 | 4685 | 0.140 |
Why?
|
| Cyclosporine | 1 | 1998 | 145 | 0.140 |
Why?
|
| Osmolar Concentration | 3 | 2006 | 176 | 0.140 |
Why?
|
| Acetates | 5 | 2001 | 73 | 0.140 |
Why?
|
| Medical Records | 2 | 2009 | 191 | 0.140 |
Why?
|
| Risk Factors | 8 | 2015 | 10296 | 0.140 |
Why?
|
| Connectome | 1 | 2019 | 104 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2015 | 141 | 0.140 |
Why?
|
| Global Health | 1 | 2002 | 570 | 0.140 |
Why?
|
| Texas | 4 | 2023 | 3581 | 0.140 |
Why?
|
| Dietary Proteins | 3 | 2015 | 252 | 0.130 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 245 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2017 | 139 | 0.130 |
Why?
|
| Health Education | 1 | 2018 | 221 | 0.130 |
Why?
|
| Body Composition | 2 | 1993 | 521 | 0.130 |
Why?
|
| Vancomycin | 1 | 1998 | 217 | 0.130 |
Why?
|
| Visceral Pain | 1 | 2016 | 7 | 0.130 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 1986 | 93 | 0.130 |
Why?
|
| Enteritis | 1 | 2016 | 54 | 0.130 |
Why?
|
| Puberty | 1 | 2016 | 95 | 0.130 |
Why?
|
| Nerve Net | 1 | 2019 | 243 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 616 | 0.130 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2012 | 19 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2021 | 4828 | 0.120 |
Why?
|
| Mental Recall | 2 | 2015 | 142 | 0.120 |
Why?
|
| Silicone Elastomers | 1 | 1995 | 35 | 0.120 |
Why?
|
| Models, Biological | 6 | 1998 | 1465 | 0.120 |
Why?
|
| Biodiversity | 1 | 2015 | 65 | 0.120 |
Why?
|
| Piperidines | 1 | 1996 | 208 | 0.120 |
Why?
|
| alpha 1-Antitrypsin | 2 | 1985 | 83 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2015 | 318 | 0.120 |
Why?
|
| Food, Formulated | 2 | 1999 | 52 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2021 | 815 | 0.110 |
Why?
|
| Rome | 1 | 2014 | 7 | 0.110 |
Why?
|
| Comorbidity | 2 | 2023 | 1528 | 0.110 |
Why?
|
| Environmental Illness | 1 | 2014 | 2 | 0.110 |
Why?
|
| Catheters, Indwelling | 3 | 2011 | 153 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1999 | 443 | 0.110 |
Why?
|
| Saliva | 1 | 2014 | 114 | 0.110 |
Why?
|
| Societies, Medical | 2 | 2012 | 700 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 876 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1987 | 429 | 0.110 |
Why?
|
| Amino Acids | 4 | 2003 | 668 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 2429 | 0.110 |
Why?
|
| Hyperalgesia | 1 | 2013 | 24 | 0.100 |
Why?
|
| Serologic Tests | 1 | 2013 | 118 | 0.100 |
Why?
|
| Physical Stimulation | 1 | 2013 | 43 | 0.100 |
Why?
|
| Hospitalization | 1 | 2021 | 1791 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2017 | 399 | 0.100 |
Why?
|
| Jejunum | 5 | 1994 | 127 | 0.100 |
Why?
|
| Kinetics | 9 | 1997 | 1333 | 0.100 |
Why?
|
| Prebiotics | 1 | 2012 | 24 | 0.100 |
Why?
|
| Appetite | 1 | 1992 | 35 | 0.100 |
Why?
|
| Blood | 1 | 1993 | 104 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 71 | 0.100 |
Why?
|
| Enteric Nervous System | 1 | 2012 | 41 | 0.100 |
Why?
|
| Rats | 7 | 2001 | 3726 | 0.100 |
Why?
|
| Aged | 7 | 2023 | 19711 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 325 | 0.100 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2012 | 37 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2009 | 1104 | 0.100 |
Why?
|
| Lactose Intolerance | 2 | 2005 | 9 | 0.100 |
Why?
|
| Bacteremia | 2 | 1994 | 407 | 0.100 |
Why?
|
| Perception | 1 | 2013 | 220 | 0.100 |
Why?
|
| Reye Syndrome | 1 | 1992 | 10 | 0.100 |
Why?
|
| Water | 3 | 2022 | 186 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2014 | 268 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2012 | 59 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 439 | 0.100 |
Why?
|
| Vitamin D Deficiency | 2 | 2024 | 73 | 0.100 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 278 | 0.100 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2023 | 97 | 0.100 |
Why?
|
| Pain Management | 1 | 2014 | 177 | 0.100 |
Why?
|
| Mexico | 1 | 2012 | 181 | 0.100 |
Why?
|
| Cholecystectomy | 1 | 2012 | 58 | 0.100 |
Why?
|
| Enterococcus | 1 | 2012 | 29 | 0.100 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 72 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 253 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2012 | 57 | 0.090 |
Why?
|
| Metagenomics | 1 | 2012 | 102 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 1996 | 945 | 0.090 |
Why?
|
| Canada | 1 | 2012 | 286 | 0.090 |
Why?
|
| Carbon Isotopes | 6 | 2001 | 277 | 0.090 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1992 | 80 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 393 | 0.090 |
Why?
|
| Reinforcement, Verbal | 1 | 2011 | 3 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1756 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 1241 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2012 | 257 | 0.090 |
Why?
|
| Critical Illness | 3 | 2024 | 600 | 0.090 |
Why?
|
| Observational Studies as Topic | 2 | 2022 | 88 | 0.090 |
Why?
|
| Nutrition Disorders | 1 | 1990 | 32 | 0.090 |
Why?
|
| Data Collection | 1 | 2012 | 381 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2010 | 104 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 258 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 53 | 0.080 |
Why?
|
| Carbon Dioxide | 5 | 1985 | 279 | 0.080 |
Why?
|
| Copper | 2 | 1994 | 63 | 0.080 |
Why?
|
| Carbohydrates | 1 | 1990 | 34 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 115 | 0.080 |
Why?
|
| Minerals | 2 | 2016 | 59 | 0.080 |
Why?
|
| Colitis | 1 | 2012 | 153 | 0.080 |
Why?
|
| Pancreas | 1 | 1991 | 220 | 0.080 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 1989 | 3 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 371 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 1987 | 280 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 193 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2012 | 323 | 0.080 |
Why?
|
| Glucagon | 6 | 1996 | 184 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2012 | 262 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 300 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 3175 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 586 | 0.080 |
Why?
|
| Rifamycins | 1 | 2009 | 21 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4406 | 0.080 |
Why?
|
| Liver | 5 | 1994 | 1748 | 0.080 |
Why?
|
| Nutritional Requirements | 4 | 2003 | 181 | 0.080 |
Why?
|
| Endoscopy | 2 | 2008 | 281 | 0.080 |
Why?
|
| Complementary Therapies | 1 | 2009 | 41 | 0.080 |
Why?
|
| Gastrectomy | 1 | 1989 | 93 | 0.080 |
Why?
|
| Fructose | 1 | 2009 | 62 | 0.080 |
Why?
|
| Colostrum | 3 | 1994 | 56 | 0.070 |
Why?
|
| Iodoacetates | 1 | 1987 | 5 | 0.070 |
Why?
|
| Antimycin A | 1 | 1987 | 6 | 0.070 |
Why?
|
| Mucous Membrane | 1 | 2008 | 89 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2018 | 4595 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2008 | 93 | 0.070 |
Why?
|
| Phylogeny | 3 | 2018 | 687 | 0.070 |
Why?
|
| Absorption | 2 | 1999 | 52 | 0.070 |
Why?
|
| Exercise | 1 | 1994 | 814 | 0.070 |
Why?
|
| Healthy Volunteers | 2 | 2020 | 134 | 0.070 |
Why?
|
| Phosphorus | 4 | 1994 | 58 | 0.070 |
Why?
|
| Nitrogen Isotopes | 2 | 1998 | 63 | 0.070 |
Why?
|
| Energy Metabolism | 4 | 1995 | 765 | 0.070 |
Why?
|
| Protein Deficiency | 1 | 1986 | 20 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2001 | 364 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 675 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 1986 | 65 | 0.070 |
Why?
|
| Glucans | 1 | 1986 | 11 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2012 | 978 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 295 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 146 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2009 | 230 | 0.060 |
Why?
|
| Splenic Neoplasms | 1 | 1986 | 12 | 0.060 |
Why?
|
| Sucrase | 3 | 1991 | 22 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2010 | 495 | 0.060 |
Why?
|
| Mitomycin | 1 | 2006 | 49 | 0.060 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2006 | 61 | 0.060 |
Why?
|
| Burns, Chemical | 1 | 2006 | 30 | 0.060 |
Why?
|
| Splanchnic Circulation | 1 | 1986 | 53 | 0.060 |
Why?
|
| Creatinine | 2 | 2012 | 394 | 0.060 |
Why?
|
| Cysteine | 2 | 2000 | 139 | 0.060 |
Why?
|
| Taurine | 1 | 2005 | 11 | 0.060 |
Why?
|
| Physicians | 1 | 2012 | 588 | 0.060 |
Why?
|
| Arteriovenous Malformations | 1 | 1986 | 47 | 0.060 |
Why?
|
| Sweetening Agents | 1 | 2005 | 34 | 0.060 |
Why?
|
| Sincalide | 1 | 2005 | 4 | 0.060 |
Why?
|
| Aminopyrine | 1 | 1985 | 7 | 0.060 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1985 | 19 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2012 | 1001 | 0.060 |
Why?
|
| Pandemics | 2 | 2024 | 1113 | 0.060 |
Why?
|
| Hypertension, Portal | 1 | 1986 | 78 | 0.060 |
Why?
|
| Infusions, Intravenous | 3 | 1999 | 554 | 0.060 |
Why?
|
| Developing Countries | 2 | 2010 | 271 | 0.060 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2025 | 19 | 0.060 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 475 | 0.060 |
Why?
|
| Hemangioma | 1 | 1986 | 94 | 0.060 |
Why?
|
| Lactic Acid | 3 | 1994 | 152 | 0.060 |
Why?
|
| Psychometrics | 2 | 2021 | 647 | 0.060 |
Why?
|
| Catheterization | 1 | 1986 | 227 | 0.060 |
Why?
|
| Random Allocation | 3 | 1994 | 439 | 0.060 |
Why?
|
| Mothers | 1 | 2007 | 356 | 0.060 |
Why?
|
| Tropical Medicine | 1 | 2005 | 104 | 0.060 |
Why?
|
| England | 1 | 2024 | 60 | 0.050 |
Why?
|
| Magnesium | 2 | 2022 | 123 | 0.050 |
Why?
|
| Lactase-Phlorizin Hydrolase | 2 | 1994 | 21 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2015 | 404 | 0.050 |
Why?
|
| Perfusion | 1 | 2005 | 206 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1633 | 0.050 |
Why?
|
| Ruminococcus | 2 | 2015 | 11 | 0.050 |
Why?
|
| Health Surveys | 2 | 2018 | 245 | 0.050 |
Why?
|
| Heartburn | 1 | 2023 | 17 | 0.050 |
Why?
|
| Registries | 2 | 2021 | 1434 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 824 | 0.050 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 173 | 0.050 |
Why?
|
| Drinking | 1 | 2023 | 34 | 0.050 |
Why?
|
| Nursing Assessment | 1 | 2003 | 24 | 0.050 |
Why?
|
| Hypoglycemia | 1 | 1985 | 192 | 0.050 |
Why?
|
| Edible Grain | 1 | 1983 | 45 | 0.050 |
Why?
|
| Nurse's Role | 1 | 2003 | 36 | 0.050 |
Why?
|
| Pediatric Nursing | 1 | 2003 | 25 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1692 | 0.050 |
Why?
|
| Psychology, Child | 1 | 2003 | 43 | 0.050 |
Why?
|
| Vitamin E | 2 | 2022 | 69 | 0.050 |
Why?
|
| Disease Progression | 2 | 2014 | 2083 | 0.050 |
Why?
|
| Potassium | 2 | 2022 | 285 | 0.050 |
Why?
|
| Mass Screening | 1 | 2009 | 785 | 0.050 |
Why?
|
| Basal Metabolism | 1 | 2003 | 95 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 1983 | 55 | 0.050 |
Why?
|
| Dietary Fats | 2 | 1994 | 294 | 0.050 |
Why?
|
| Linear Models | 2 | 2016 | 683 | 0.050 |
Why?
|
| Epinephrine | 2 | 2001 | 178 | 0.050 |
Why?
|
| Nutritional Support | 1 | 2023 | 56 | 0.050 |
Why?
|
| Vitamin B 6 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2005 | 338 | 0.050 |
Why?
|
| Thiamine | 1 | 2022 | 8 | 0.050 |
Why?
|
| Osteomalacia | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1983 | 264 | 0.050 |
Why?
|
| Models, Chemical | 2 | 1997 | 86 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2024 | 229 | 0.050 |
Why?
|
| Homeostasis | 2 | 2010 | 704 | 0.050 |
Why?
|
| Fasting | 2 | 1991 | 293 | 0.050 |
Why?
|
| Consumer Product Safety | 1 | 2002 | 32 | 0.050 |
Why?
|
| Food Contamination | 1 | 2002 | 23 | 0.050 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2022 | 30 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 78 | 0.050 |
Why?
|
| CD56 Antigen | 1 | 2021 | 26 | 0.050 |
Why?
|
| Hygiene | 1 | 2002 | 27 | 0.050 |
Why?
|
| Environmental Pollution | 1 | 2002 | 13 | 0.050 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 28 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2057 | 0.050 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2021 | 8 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 275 | 0.050 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2021 | 2 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 190 | 0.050 |
Why?
|
| Birth Weight | 3 | 1999 | 346 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2001 | 176 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 92 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 248 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2002 | 117 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2021 | 168 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2001 | 126 | 0.040 |
Why?
|
| Aging | 3 | 1998 | 1182 | 0.040 |
Why?
|
| Cholic Acids | 1 | 2020 | 16 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 1763 | 0.040 |
Why?
|
| Hyperammonemia | 1 | 2001 | 63 | 0.040 |
Why?
|
| Phosphocreatine | 3 | 1996 | 9 | 0.040 |
Why?
|
| Contraindications | 1 | 2000 | 78 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 231 | 0.040 |
Why?
|
| Pregnancy | 3 | 2024 | 7225 | 0.040 |
Why?
|
| Trace Elements | 1 | 2000 | 27 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 274 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1427 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2000 | 96 | 0.040 |
Why?
|
| Complement C2 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Dopamine | 1 | 2001 | 282 | 0.040 |
Why?
|
| Safety | 1 | 2000 | 217 | 0.040 |
Why?
|
| Equipment Failure | 2 | 2011 | 121 | 0.040 |
Why?
|
| Carbon | 2 | 1994 | 92 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2019 | 83 | 0.040 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 58 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2414 | 0.040 |
Why?
|
| Oxidation-Reduction | 3 | 1986 | 442 | 0.040 |
Why?
|
| Liver Glycogen | 2 | 1991 | 23 | 0.040 |
Why?
|
| Lung | 1 | 1987 | 1487 | 0.040 |
Why?
|
| Aspartic Acid | 2 | 1992 | 73 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1992 | 665 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 168 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 149 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 1999 | 59 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 556 | 0.040 |
Why?
|
| Food Labeling | 1 | 2018 | 10 | 0.040 |
Why?
|
| Poverty | 1 | 2002 | 421 | 0.040 |
Why?
|
| Propensity Score | 1 | 2019 | 222 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 53 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 493 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 538 | 0.040 |
Why?
|
| Astrocytes | 1 | 2001 | 250 | 0.040 |
Why?
|
| Lipids | 2 | 2000 | 522 | 0.040 |
Why?
|
| Atrophy | 3 | 2012 | 231 | 0.040 |
Why?
|
| Logistic Models | 2 | 2017 | 1802 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2018 | 120 | 0.030 |
Why?
|
| Muscle Contraction | 2 | 1996 | 188 | 0.030 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1997 | 11 | 0.030 |
Why?
|
| Biological Transport | 1 | 1998 | 355 | 0.030 |
Why?
|
| Aerobiosis | 2 | 1987 | 13 | 0.030 |
Why?
|
| Anaerobiosis | 2 | 1987 | 12 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1720 | 0.030 |
Why?
|
| Cimetidine | 1 | 1996 | 14 | 0.030 |
Why?
|
| Nucleotides | 2 | 1989 | 91 | 0.030 |
Why?
|
| Cognition | 1 | 1982 | 721 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1998 | 171 | 0.030 |
Why?
|
| Ranitidine | 1 | 1996 | 32 | 0.030 |
Why?
|
| Neoplasms | 2 | 1988 | 2799 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 292 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 133 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2016 | 55 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 1901 | 0.030 |
Why?
|
| Vitamin A | 2 | 2014 | 59 | 0.030 |
Why?
|
| Anti-Ulcer Agents | 1 | 1996 | 115 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 1996 | 38 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 501 | 0.030 |
Why?
|
| Staphylococcal Infections | 2 | 1994 | 561 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1996 | 255 | 0.030 |
Why?
|
| Chromatography | 1 | 1995 | 44 | 0.030 |
Why?
|
| Social Class | 1 | 2017 | 190 | 0.030 |
Why?
|
| Environment | 1 | 2016 | 142 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2016 | 136 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 15 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 1986 | 1316 | 0.030 |
Why?
|
| Child Health Services | 1 | 2016 | 87 | 0.030 |
Why?
|
| Risk | 3 | 1987 | 759 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 625 | 0.030 |
Why?
|
| Gammaproteobacteria | 1 | 2015 | 16 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1999 | 459 | 0.030 |
Why?
|
| Urinalysis | 1 | 1995 | 62 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2015 | 74 | 0.030 |
Why?
|
| Bacillus | 1 | 2015 | 35 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 150 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 887 | 0.030 |
Why?
|
| Corn Oil | 1 | 1994 | 11 | 0.030 |
Why?
|
| Fats | 1 | 1994 | 12 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 1994 | 33 | 0.030 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 23 | 0.030 |
Why?
|
| Sialorrhea | 1 | 2014 | 16 | 0.030 |
Why?
|
| Bilirubin | 2 | 2005 | 125 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 65 | 0.030 |
Why?
|
| Radiography | 2 | 2015 | 809 | 0.030 |
Why?
|
| Polysomnography | 1 | 2015 | 145 | 0.030 |
Why?
|
| Staphylococcus | 1 | 1994 | 69 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1994 | 136 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 197 | 0.030 |
Why?
|
| Fish Oils | 1 | 2014 | 85 | 0.030 |
Why?
|
| Spices | 1 | 2013 | 3 | 0.030 |
Why?
|
| Dipeptides | 1 | 1994 | 57 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 68 | 0.030 |
Why?
|
| Bicarbonates | 2 | 1984 | 99 | 0.030 |
Why?
|
| C-Peptide | 1 | 1994 | 113 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 218 | 0.030 |
Why?
|
| Somatostatin | 1 | 1994 | 70 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2014 | 81 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 83 | 0.030 |
Why?
|
| Allergens | 1 | 2015 | 252 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2013 | 75 | 0.030 |
Why?
|
| Erythrocytes | 2 | 1992 | 219 | 0.030 |
Why?
|
| Mast Cells | 1 | 2013 | 78 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 10 | 0.030 |
Why?
|
| Focus Groups | 1 | 2013 | 193 | 0.030 |
Why?
|
| Drinking Water | 1 | 2012 | 14 | 0.030 |
Why?
|
| Gelsolin | 1 | 2012 | 13 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 1992 | 25 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1993 | 55 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2652 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2014 | 252 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 17743 | 0.030 |
Why?
|
| Behavior | 1 | 2012 | 73 | 0.020 |
Why?
|
| RNA | 3 | 1992 | 574 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 376 | 0.020 |
Why?
|
| Creatine | 1 | 1992 | 41 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2012 | 47 | 0.020 |
Why?
|
| Respiration | 3 | 2007 | 122 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1992 | 232 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 199 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1992 | 262 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1989 | 233 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 761 | 0.020 |
Why?
|
| Calcium | 2 | 1994 | 1105 | 0.020 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 11 | 0.020 |
Why?
|
| DNA | 4 | 1992 | 1619 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 123 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 1996 | 642 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1992 | 172 | 0.020 |
Why?
|
| Genomics | 1 | 2019 | 1520 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 1991 | 106 | 0.020 |
Why?
|
| Ligation | 1 | 1991 | 133 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 551 | 0.020 |
Why?
|
| Neurons | 1 | 2001 | 1943 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 234 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 431 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1992 | 118 | 0.020 |
Why?
|
| Reference Values | 2 | 2006 | 719 | 0.020 |
Why?
|
| Duodenum | 2 | 1988 | 101 | 0.020 |
Why?
|
| Body Weight | 2 | 1999 | 989 | 0.020 |
Why?
|
| Emotions | 1 | 2012 | 347 | 0.020 |
Why?
|
| Incidence | 2 | 2011 | 3134 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 812 | 0.020 |
Why?
|
| Epithelium | 1 | 1990 | 365 | 0.020 |
Why?
|
| Pamphlets | 1 | 1989 | 22 | 0.020 |
Why?
|
| Xylose | 1 | 1989 | 9 | 0.020 |
Why?
|
| Tropical Climate | 1 | 2009 | 49 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 465 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1988 | 15 | 0.020 |
Why?
|
| Calcium Gluconate | 1 | 1988 | 6 | 0.020 |
Why?
|
| Acetic Acid | 1 | 1988 | 18 | 0.020 |
Why?
|
| Protons | 1 | 1989 | 93 | 0.020 |
Why?
|
| Solubility | 1 | 1988 | 139 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1989 | 250 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 1989 | 74 | 0.020 |
Why?
|
| Etoposide | 1 | 1988 | 115 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 257 | 0.020 |
Why?
|
| Iodoacetic Acid | 1 | 1987 | 2 | 0.020 |
Why?
|
| Sugar Phosphates | 1 | 1987 | 3 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1989 | 335 | 0.020 |
Why?
|
| Asthma | 1 | 2015 | 756 | 0.020 |
Why?
|
| Body Water | 2 | 1986 | 90 | 0.020 |
Why?
|
| Software | 1 | 2012 | 687 | 0.020 |
Why?
|
| Electrolytes | 2 | 1986 | 53 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 819 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3602 | 0.020 |
Why?
|
| Acute Disease | 1 | 1990 | 1096 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1989 | 240 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1989 | 184 | 0.020 |
Why?
|
| Glycolysis | 1 | 1987 | 151 | 0.020 |
Why?
|
| Hair Color | 1 | 1986 | 12 | 0.020 |
Why?
|
| Skin Diseases, Infectious | 1 | 1987 | 24 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 1986 | 34 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1987 | 305 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1992 | 1705 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 887 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1996 | 1271 | 0.020 |
Why?
|
| Energy Transfer | 1 | 1985 | 16 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 2005 | 13 | 0.020 |
Why?
|
| Rabbits | 1 | 1986 | 718 | 0.020 |
Why?
|
| Cholagogues and Choleretics | 1 | 2005 | 25 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1989 | 443 | 0.020 |
Why?
|
| Duodenal Ulcer | 1 | 1986 | 127 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1985 | 11 | 0.020 |
Why?
|
| Fatty Liver | 1 | 1987 | 190 | 0.020 |
Why?
|
| Sepsis | 2 | 1987 | 483 | 0.020 |
Why?
|
| Immunoelectrophoresis, Two-Dimensional | 1 | 1985 | 2 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1985 | 22 | 0.020 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1985 | 7 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1986 | 581 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 1987 | 161 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 231 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 309 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 511 | 0.010 |
Why?
|
| Skin Ulcer | 1 | 1984 | 32 | 0.010 |
Why?
|
| Triglycerides | 1 | 1987 | 576 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1986 | 258 | 0.010 |
Why?
|
| Hormones | 1 | 1984 | 186 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1983 | 71 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 694 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2002 | 81 | 0.010 |
Why?
|
| Problem Solving | 1 | 1982 | 63 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 4269 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2006 | 356 | 0.010 |
Why?
|
| Intelligence | 1 | 1982 | 100 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2251 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1984 | 465 | 0.010 |
Why?
|
| Mitochondria | 1 | 1985 | 679 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1982 | 181 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 939 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1985 | 866 | 0.010 |
Why?
|
| Ileostomy | 1 | 1997 | 31 | 0.010 |
Why?
|
| Glucosephosphates | 1 | 1996 | 2 | 0.010 |
Why?
|
| Glucose-6-Phosphate | 1 | 1996 | 3 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1996 | 49 | 0.010 |
Why?
|
| Organic Chemicals | 2 | 1986 | 58 | 0.010 |
Why?
|
| Microvilli | 1 | 1994 | 71 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1994 | 61 | 0.010 |
Why?
|
| Coagulase | 1 | 1994 | 23 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1994 | 50 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1994 | 76 | 0.010 |
Why?
|
| Phospholipids | 1 | 1994 | 105 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1994 | 404 | 0.010 |
Why?
|
| Sodium | 1 | 1994 | 299 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 1993 | 22 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 2299 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 3431 | 0.010 |
Why?
|
| Thyroxine | 1 | 1992 | 65 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1994 | 343 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 461 | 0.010 |
Why?
|
| Cholesterol | 1 | 1994 | 541 | 0.010 |
Why?
|
| Bone Density | 1 | 1993 | 319 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 1240 | 0.010 |
Why?
|
| Organ Size | 1 | 1991 | 441 | 0.010 |
Why?
|
| Consumer Behavior | 1 | 1989 | 38 | 0.000 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1988 | 76 | 0.000 |
Why?
|
| Kidney | 1 | 1994 | 1363 | 0.000 |
Why?
|
| Hydroxycholecalciferols | 1 | 1986 | 6 | 0.000 |
Why?
|
| Esophagitis | 1 | 1986 | 40 | 0.000 |
Why?
|
| Proteins | 1 | 1991 | 1039 | 0.000 |
Why?
|
| Portal Vein | 1 | 1985 | 91 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 143 | 0.000 |
Why?
|
| Alanine | 1 | 1985 | 187 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 99 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1984 | 105 | 0.000 |
Why?
|
| Mouth Diseases | 1 | 1984 | 12 | 0.000 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1986 | 143 | 0.000 |
Why?
|
| Sodium Bicarbonate | 1 | 1984 | 56 | 0.000 |
Why?
|
| Ulcer | 1 | 1984 | 49 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1986 | 171 | 0.000 |
Why?
|
| Mathematics | 1 | 1983 | 97 | 0.000 |
Why?
|
| Muscle Proteins | 1 | 1986 | 413 | 0.000 |
Why?
|